A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma

Published:2017-12-02 Issue:67 Volume:8 Page:110849-110860
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Shi Guodong¹²,Zhang Jingjing¹²,Lu Zipeng¹²,Liu Dongfang¹²,Wu Yang¹²,Wu Pengfei¹²,Yin Jie¹²,Yuan Hao¹²,Zhu Qicong¹²,Chen Lei¹²,Fu Yue¹²,Peng Yunpeng¹²,Wang Yan³,Jiang Kuirong¹²,Miao Yi¹²

Affiliation:

1. Pancreas Center, Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

2. Pancreas Institute of Nanjing Medical University, Nanjing 210029, China

3. Endoscopy Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Immunity-Related Gene Model Predicts Prognosis in Cholangiocarcinoma;Frontiers in Oncology;2022-07-01

2. Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection;PeerJ;2021-11-26

3. A Novel Ferroptosis-Related Gene Signature Predicts Recurrence in Patients With Pancreatic Ductal Adenocarcinoma;Frontiers in Molecular Biosciences;2021-09-23

4. Overexpression of abnormal spindle-like microcephaly-associated (ASPM) increases tumor aggressiveness and predicts poor outcome in patients with lung adenocarcinoma;Translational Cancer Research;2021-02

5. A novel 20-gene prognostic score in pancreatic adenocarcinoma;PLOS ONE;2020-04-20